Your Complete Guide to Wegovy and Mounjaro Dosing
Understanding Wegovy to Mounjaro Conversion Chart Fundamentals
When comparing a Wegovy to Mounjaro conversion chart, it's essential to understand that these medications operate through distinct mechanisms, making direct dose-to-dose equivalencies complex. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors simultaneously. This dual-action approach means Mounjaro's dosing schedule follows a different escalation pattern than Wegovy's established 0.25mg to 2.4mg progression. Both prescription-only medicines require careful titration under prescriber supervision to minimise side effects and optimise effectiveness. EverydayMeds stocks complete dose ranges for both medications, eliminating the need to switch pharmacies during your treatment journey.
The conversion between these treatments isn't simply mathematical—it requires clinical judgement based on your current dose, tolerance, and treatment response. Wegovy's maintenance dose of 2.4mg weekly represents the culmination of a 16-week escalation protocol, whilst Mounjaro's maintenance can reach 15mg weekly following its own titration schedule. Both medications must be used alongside a reduced-calorie diet and increased physical activity for optimal results. Your prescriber will consider factors including your current dose stability, side effect profile, and treatment goals when creating your personalised Wegovy to Mounjaro conversion chart. Our clinical team at EverydayMeds (GPhC #9012878) ensures seamless prescription management throughout any transition period.
Comprehensive Pricing and Dose Availability
EverydayMeds maintains complete stock of all Wegovy doses to support your entire treatment progression without interruption. Our single pen pricing starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and reaching the 2.4mg maintenance dose at £209.99. New customers apply code FIRST40 at checkout to secure these rates, whilst returning customers use code DOSE25 for continued savings. For patients planning ahead or requiring treatment continuity, our Intro Trio bundle (0.25mg, 0.5mg, and 1mg) provides three months of escalation doses for £299.99. The Ultimate Stability Trio offers three maintenance 2.4mg pens for £649.99, ensuring uninterrupted long-term treatment supply.
Bundle options specifically support patients transitioning between treatments or requiring flexible dosing schedules during conversion periods. Our Progress Duo combines 0.5mg and 1mg doses for £189.99, ideal for patients stepping down from higher Mounjaro doses or managing titration adjustments. For those requiring extended time at specific doses during conversion, our Consistency bundles provide two identical pens—such as Consistency 1.7mg for £309.99 when your prescriber recommends extended stabilisation. All bundles include next-day cold-chain delivery and comprehensive dosing guidance. Whether you're starting fresh or converting from Mounjaro, our complete inventory ensures your Wegovy to Mounjaro conversion chart planning never encounters supply interruptions.
Clinical Evidence Supporting Treatment Decisions
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes across the STEP programme. STEP 1 demonstrated approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 2 showed 9.6% average weight loss in patients with type 2 diabetes. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major adverse cardiovascular events (hazard ratio 0.80), highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's SURMOUNT trials demonstrated its own efficacy profile through the dual GIP/GLP-1 mechanism, though direct head-to-head comparisons between trials aren't appropriate due to different study populations and endpoints. Both medications showed sustained benefits when continued long-term, with weight regain observed when treatment ceased. The STEP 1 extension study indicated patients regained approximately two-thirds of lost weight within one year of stopping Wegovy, emphasising that weight management represents a long-term commitment rather than a short-term intervention.
How Wegovy Works in Your Wegovy to Mounjaro Conversion Chart
Wegovy operates as a GLP-1 receptor agonist, mimicking the action of naturally occurring incretin hormones that regulate appetite and satiety. When you inject Wegovy weekly using the convenient FlexTouch pen, semaglutide binds to GLP-1 receptors throughout your body, particularly in the brain areas controlling hunger and food intake. This binding action reduces appetite signals, promotes feelings of fullness after smaller meals, and may diminish food cravings by modulating reward pathways. The medication also slows gastric emptying, meaning food remains in your stomach longer, contributing to sustained satiety between meals. Unlike rapid-acting appetite suppressants, Wegovy provides consistent appetite modulation throughout the week, supporting sustainable eating pattern changes when combined with lifestyle modifications. Understanding this mechanism helps explain why Wegovy to Mounjaro conversion charts require careful consideration of each medication's distinct receptor activity profiles.
Streamlined Ordering Process for Treatment Transitions
Obtaining Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture your medical history, current medications, and weight management goals. This assessment specifically accommodates patients transitioning from other treatments, including detailed questions about your current Mounjaro dose, treatment duration, and any side effects experienced. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), considering factors relevant to your Wegovy to Mounjaro conversion chart planning. Once approved, your medication ships via next-day cold-chain delivery in temperature-controlled packaging, maintaining the 2-8°C storage requirements throughout transit. Our pharmacy team (GPhC #9012878) coordinates with your prescriber to ensure seamless prescription management during any treatment transition period, eliminating gaps in your weight management therapy.
Storage Advantages and Practical Considerations
Wegovy offers significant storage flexibility compared to Mounjaro, particularly beneficial during treatment transitions or travel periods. Whilst both medications require refrigeration at 2-8°C before first use, Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy ideal for patients with unpredictable schedules or frequent travel requirements. The FlexTouch pen delivery system provides precise dosing with easy-to-read dose windows and audible click confirmation when injection completes. Dose escalation follows a mandatory schedule—0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg maintenance from week 17 onwards. Understanding these practical differences helps inform your Wegovy to Mounjaro conversion chart decision-making process alongside your prescriber's clinical guidance.
Complete Dose Range Support Throughout Your Journey
EverydayMeds' comprehensive inventory management ensures every Wegovy dose remains available when your conversion timeline requires it. Unlike pharmacies with limited stock ranges, our complete 0.25mg through 2.4mg availability means your Wegovy to Mounjaro conversion chart planning never encounters supply constraints or forced treatment interruptions. We maintain elevated stock levels of transitional doses (1mg and 1.7mg) specifically for patients converting from Mounjaro, where prescribers often recommend extended stabilisation periods at intermediate strengths. Our inventory forecasting anticipates seasonal demand fluctuations and supply chain variations, ensuring consistent availability regardless of broader market conditions.
This complete range support extends beyond simple stock availability to include flexible bundle configurations tailored for conversion scenarios. Patients stepping down from higher Mounjaro doses might benefit from our Take-It-Slow bundles, allowing extended time at each Wegovy escalation stage. Conversely, those experiencing excellent tolerance might prefer our Step-Up bundles for standard progression timing. Our clinical team collaborates with your prescriber to recommend optimal bundle selections based on your specific Wegovy to Mounjaro conversion chart requirements, ensuring cost-effective treatment continuity throughout the transition process.
Start Your Treatment Transition Today
Ready to explore your Wegovy to Mounjaro conversion options with complete dose availability? Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and connect with our qualified prescribers who specialise in weight management transitions. New customers save with code FIRST40 at checkout, whilst returning customers continue their savings with code DOSE25 for all subsequent orders. Our comprehensive stock levels ensure your treatment plan never encounters supply interruptions, whether you're starting your first escalation dose or maintaining long-term therapy at 2.4mg. Remember that both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which medication aligns best with your individual health goals and treatment response. Don't let stock limitations at other pharmacies compromise your weight management journey when EverydayMeds ensures complete dose range availability throughout your entire treatment progression.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
